Heck Capital Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-354
Closed -$15.3K 198
2025
Q1
$15.3K Buy
+354
New +$17.9K ﹤0.01% 202
2022
Q2
Sell
-3,781
Closed -$264K 144
2022
Q1
$264K Sell
3,781
-32
-0.8% -$2.34K 0.05% 108
2021
Q4
$297K Sell
3,813
-275
-7% -$24.3K 0.05% 101
2021
Q3
$390K Sell
4,088
-66
-2% -$6.97K 0.08% 93
2021
Q2
$516K Buy
4,154
+60
+1% +$7.16K 0.1% 87
2021
Q1
$540K Sell
4,094
-1,095
-21% -$150K 0.12% 79
2020
Q4
$687K Sell
5,189
-1,594
-23% -$193K 0.17% 62
2020
Q3
$692K Buy
6,783
+536
+9% +$46.3K 0.19% 47
2020
Q2
$543K Buy
6,247
+1,676
+37% +$134K 0.11% 51
2020
Q1
$265K Buy
4,571
+2,692
+143% +$219K 0.08% 65
2019
Q4
$174K Buy
+1,879
New +$165K 0.04% 92

Other funds holding EXAS

Heck Capital Advisors's EXAS Position: Q2 2025 in Review

Heck Capital Advisors sold out of Exact Sciences (EXAS) in Q2 2025, closing a stake of 354 shares — an estimated $15.3K sold.

Heck Capital Advisors first reported a position in EXAS in Q4 2019 and held it in 11 quarters. The position peaked at $692K in Q3 2020. 558 funds tracked by Wall St. Rank hold EXAS as of Q2 2025.

  • Heck Capital Advisors reported no remaining Exact Sciences position as of Q2 2025 after selling out during the quarter.
  • Heck Capital Advisors sold 354 Exact Sciences shares in Q2 2025, an estimated $15.3K.
  • Heck Capital Advisors first reported a position in Exact Sciences in Q4 2019 and held it in 11 quarters.
  • Heck Capital Advisors's Exact Sciences position peaked at $692K in Q3 2020.
  • 558 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2025.

Based on Heck Capital Advisors's 13F filing for Q2 2025, filed 23 Jul 2025.